Your browser doesn't support javascript.
loading
Clinical outcomes of patients with ductal carcinoma in situ in Hong Kong: 10-year territory-wide cancer registry study.
Co, M; Ngan, R K C; Mang, O W K; Tam, A H P; Wong, K H; Kwong, A.
Afiliación
  • Co M; Division of Breast Surgery, Department of Surgery, The University of Hong Kong, Hong Kong.
  • Ngan RKC; Department of Surgery, Queen Mary Hospital, Hong Kong.
  • Mang OWK; Department of Clinical Oncology, The University of Hong Kong, Hong Kong.
  • Tam AHP; Hong Kong Cancer Registry, Hospital Authority, Hong Kong.
  • Wong KH; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong.
  • Kwong A; Hong Kong Cancer Registry, Hospital Authority, Hong Kong.
Hong Kong Med J ; 26(6): 486-491, 2020 Dec.
Article en En | MEDLINE | ID: mdl-33277445
BACKGROUND: Incidence of ductal carcinoma in situ (DCIS) has increased in recent decades because of breast cancer screening. This study comprised a long-term survival analysis of DCIS using 10-year territory-wide data from the Hong Kong Cancer Registry. METHODS: This study included all patients diagnosed with DCIS in Hong Kong from 1997 to 2006. Exclusion criteria were age <30 years or ≥70 years, lobular carcinoma in situ, Paget's disease, and co-existing invasive carcinoma. Patients were stratified into those diagnosed from 1997 to 2001 and those diagnosed from 2002 to 2006. The 5- and 10-year breast cancer-specific survival rates were evaluated; standardised mortality ratios were calculated. RESULTS: Among the 1391 patients in this study, 449 were diagnosed from 1997 to 2001, and 942 were diagnosed from 2002 to 2006. The mean age at diagnosis was 49.2±9.2 years. Overall, 51.2% of patients underwent mastectomy and 29.5% received adjuvant radiotherapy. The median follow-up interval was 11.6 years; overall breast cancer-specific mortality rates were 0.3% and 0.9% after 5 and 10 years of follow-up, respectively. In total, 109 patients (7.8%) developed invasive breast cancer after a considerable delay. Invasive breast cancer rates were comparable between patients diagnosed from 1997 to 2001 (n=37, 8.2%) and those diagnosed from 2002 to 2006 (n=72, 7.6%). CONCLUSION: Despite excellent long-term survival among patients with DCIS, these patients were more likely to die of breast cancer, compared with the general population of women in Hong Kong.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Carcinoma Intraductal no Infiltrante / Detección Precoz del Cáncer Tipo de estudio: Diagnostic_studies / Evaluation_studies / Incidence_studies / Prognostic_studies / Screening_studies Límite: Adult / Aged / Female / Humans / Middle aged País/Región como asunto: Asia Idioma: En Revista: Hong Kong Med J Asunto de la revista: MEDICINA Año: 2020 Tipo del documento: Article País de afiliación: Hong Kong Pais de publicación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Carcinoma Intraductal no Infiltrante / Detección Precoz del Cáncer Tipo de estudio: Diagnostic_studies / Evaluation_studies / Incidence_studies / Prognostic_studies / Screening_studies Límite: Adult / Aged / Female / Humans / Middle aged País/Región como asunto: Asia Idioma: En Revista: Hong Kong Med J Asunto de la revista: MEDICINA Año: 2020 Tipo del documento: Article País de afiliación: Hong Kong Pais de publicación: China